Literature DB >> 9482941

Expression of Q227L-galphas in MCF-7 human breast cancer cells inhibits tumorigenesis.

J Chen1, J A Bander, T A Santore, Y Chen, P T Ram, M J Smit, R Iyengar.   

Abstract

The effects of expression of mutant (Q227L)-activated Galphas and elevation of cAMP on mitogen-activating protein kinase (MAPK) activity and the transformed phenotype were studied in the MCF-7 human mammary epithelial cell line. Elevation of cAMP partially inhibited the epidermal growth factor-stimulated DNA synthesis and the intrinsic MAPK (ERK-1 and ERK-2) of serum-starved MCF-7 cells. Addition of 8Br-cAMP or expression of mutant (Q227L)-activated Galphas in MCF-7 cells blocked the ability of these cells to grow in an anchorage-independent manner, as assessed by colony formation in soft agar. 8Br-cAMP in the culture medium also blocked estrogen stimulation of MCF-7 cell proliferation in vitro. MCF-7 cells expressing Q227L-Galphas grew very slowly in vitro, and when these cells were injected s.c. into athymic mice implanted with estrogen pellets, the frequency of tumor formation was reduced greatly and the sizes of the tumors formed were much smaller than those in mice injected with MCF-7 cells that had been transfected with the empty vector. These results indicate that the intracellular levels of cAMP in transformed mammary epithelial cells can be a crucial factor in determining the expression of the transformed phenotype. Interactions between the Gs/adenylyl cyclase and MAPK-1,2 signaling pathways could be one mechanism by which expression of the transformed phenotype in mammary epithelial cells are regulated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482941      PMCID: PMC19449          DOI: 10.1073/pnas.95.5.2648

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II.

Authors:  T W Sturgill; L B Ray; E Erikson; J L Maller
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

Review 2.  Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma.

Authors:  R B Dickson; M E Lippman
Journal:  Endocr Rev       Date:  1987-02       Impact factor: 19.871

3.  The pathway to signal achievement.

Authors:  S E Egan; R A Weinberg
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

4.  Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice.

Authors:  H D Soule; C M McGrath
Journal:  Cancer Lett       Date:  1980-08       Impact factor: 8.679

5.  Inhibition by cAMP of Ras-dependent activation of Raf.

Authors:  S J Cook; F McCormick
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

Review 6.  Role of site-selective cAMP analogs in the control and reversal of malignancy.

Authors:  Y S Cho-Chung; T Clair; G Tortora; H Yokozaki
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

7.  Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

Authors:  C R King; M H Kraus; S A Aaronson
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

8.  Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth.

Authors:  R B Dickson; M E McManaway; M E Lippman
Journal:  Science       Date:  1986-06-20       Impact factor: 47.728

9.  The response of breast cancer cells to steroid and peptide growth factors.

Authors:  J Godden; R Leake; D J Kerr
Journal:  Anticancer Res       Date:  1992 Sep-Oct       Impact factor: 2.480

10.  Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase.

Authors:  S A Moodie; B M Willumsen; M J Weber; A Wolfman
Journal:  Science       Date:  1993-06-11       Impact factor: 47.728

View more
  14 in total

1.  Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector.

Authors:  R Ramalingam; S Rafii; S Worgall; N R Hackett; R G Crystal
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Adenovirus-directed expression of Q227L-G alpha(s) inhibits growth of established tumors of later-stage human breast cancer cells in athymic mice.

Authors:  Tara Ann Santore; Yibang Chen; Martine J Smit; Ravi Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Expression of Q227L-Galpha(s) inhibits intimal vessel wall hyperplasia after balloon injury.

Authors:  W Holness; T A Santore; G P Brown; J T Fallon; M B Taubman; R Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

4.  Identification of new Gβγ interaction sites in adenylyl cyclase 2.

Authors:  Aislyn D W Boran; Yibang Chen; Ravi Iyengar
Journal:  Cell Signal       Date:  2011-05-08       Impact factor: 4.315

Review 5.  Heterotrimeric G proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes.

Authors:  Vijay Yanamadala; Hideyuki Negoro; Bradley M Denker
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

6.  Identity of adenylyl cyclase isoform determines the rate of cell cycle progression in NIH 3T3 cells.

Authors:  M J Smit; D Verzijl; R Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Reduced eukaryotic initiation factor 2Bepsilon-subunit expression suppresses the transformed phenotype of cells overexpressing the protein.

Authors:  James W Gallagher; Neil Kubica; Scot R Kimball; Leonard S Jefferson
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

8.  Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses.

Authors:  Dragoslava Zivadinovic; Bahiru Gametchu; Cheryl S Watson
Journal:  Breast Cancer Res       Date:  2004-11-24       Impact factor: 6.466

9.  N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth.

Authors:  Wenqing Cao; ZhiFan Ma; Mark M Rasenick; ShuYan Yeh; JiangZhou Yu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway.

Authors:  Arijit Bhowmik; Nilanjana Das; Uttam Pal; Madhumita Mandal; Seemana Bhattacharya; Moumita Sarkar; Parasuraman Jaisankar; Nakul C Maiti; Mrinal K Ghosh
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.